ArticleBMC cancer2018

Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro.

Ozlem Aslan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.